Self-efficacy-based Auditory Rehabilitation to Optimize Real-world Outcomes With Over-the-Counter Hearing Aids: A Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This goal of this study is to learn if a new audiology treatment process called the self-efficacy-based auditory rehabilitation (SEBAR) can improve confidence and success with over-the-counter (OTC) hearing aids. The main questions it aims to answer are: * Can the SEBAR improve participants' confidence related to managing their over-the-counter hearing aids? * Can the SEBAR improve participants' willingness to adopt over-the-counter hearing aids, their satisfaction, quality of life, and their emotional state? Researchers will compare these outcomes of the SEBAR with and without wearing OTC hearing aids. Participants will: * Visit for one appointment to complete a few questionnaires without OTC hearing aids * Wear a pair of ITC hearing aids for a week and use an app to answer questions about their experiences * Visit for a second appointment to complete the same questionnaires with OTC hearing aids.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• Between 18 - 85 years old

‣ Non-fluctuating, adult-onset, bilateral mild-to-moderate sensorineural hearing loss (average hearing thresholds for 500-3000Hz between 25- and 60-dB HL and no more than 10 dB difference between ears).

⁃ No previous experience with hearing aids

⁃ English as their first language with good self-reported health

Locations
United States
Arkansas
Department of Audiology, University of Arkansas for Medical Sciences
RECRUITING
Little Rock
Contact Information
Primary
Lipika Sarangi, Doctor of Philosophy
LSarangi@uams.edu
501-526-5602
Time Frame
Start Date: 2024-10-30
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 27
Treatments
Experimental: Pre-post single arm design
Participants will wear the hearing aids for a week while receiving the SEBAR. Outcomes will be assessed with and without hearing aids.
Related Therapeutic Areas
Sponsors
Leads: University of Arkansas

This content was sourced from clinicaltrials.gov

Similar Clinical Trials